Skip to content
Back to Blog

Deep Tech and Frontier Tech: Why Capital Is Flowing Back

Deep tech — hard science, hardware, biotech, energy, robotics, frontier compute — took its largest share of new venture capital since 2014 in 2024–2026, driven by compressed SaaS multiples, exploding AI infrastructure demand, and a growing recognition that the only durable moat against frontier labs requires owning something physical or scientific that can’t be replicated by a model update. Exit multiples for deep tech companies with real IP moats reach 10–20x revenue — higher than SaaS — and government co-investment from programs like the CHIPS Act and IRA climate provisions now de-risks early-stage rounds. This post explains what investors mean by deep tech, the metrics they use when ARR doesn’t exist, and the single trap that kills deep tech companies before they reach commercial scale.

What investors mean by “deep tech”

It’s a loose category, but the working definition that most investors apply: companies whose core technology requires meaningful R&D before product-market fit, and whose competitive moat is rooted in IP, manufacturing process, or scientific capability — not go-to-market execution. Robotics, novel chip architectures, fusion energy, synthetic biology, climate hardware, advanced materials, and quantum computing all qualify. What they share: long development timelines, high capital requirements, and much larger potential outcomes if the science works.

Why this is venture-fundable again

  • Larger fund sizes and longer fund lifespans mean LPs can accept 12–15 year holds for the right opportunity. A decade ago, most funds had 10-year hard closes; now 12–15 year extensions are common.
  • Government and strategic capital — the US CHIPS Act, IRA climate provisions, UK ARIA, European sovereign innovation funds, DARPA, ARPA-E — now co-invests alongside VC at meaningful scale, reducing dilution risk for the company while adding credibility.
  • Exit multiples for deep tech companies with real moats are higher than SaaS at comparable revenue: 10–20x revenue multiples are achievable, and strategic acquisitions by large industrial, pharmaceutical, or defense companies often happen at significant premiums.
  • The AI wave created a secondary demand for deep tech: new chip architectures, energy-dense power for data centers, novel cooling systems, and advanced manufacturing for AI hardware are all deep tech plays that benefit directly from AI capex.

The metrics investors actually look at

Deep tech doesn’t have ARR at Seed. Investors evaluate:

  • Technical milestones: TRL (Technology Readiness Level) movement from 3 to 5 to 7, demonstrated lab-to-pilot transitions with reproducible results.
  • Team density: PhDs from credible research institutions, combined with at least one founder who has prior commercialisation or engineering-at-scale experience. “World-class scientist” alone is not enough.
  • IP position: granted patents, exclusive licences, trade secrets with documented provenance, or a manufacturing process that can’t be easily replicated.
  • Capital efficiency: cost to the next commercially meaningful milestone, not just the next press release. Investors want to see a clear, achievable line between their check and the inflection that unlocks the next fund.
  • Pull from strategics or governments: signed LOIs, paid grants, design wins with industrial partners — third-party validation that the technology solves a real problem.

The trap

Deep tech founders routinely raise too little for too ambitious a milestone. The pattern: $3M Seed for a $30M problem. The result: a milestone gets hit but it’s not commercially meaningful — it’s a lab demonstration that doesn’t unlock the next funding round. Investors pass, the company bridges on bad terms, and momentum stalls. Raise to a real commercial inflection point, even if it requires raising more or taking longer to find the right capital.

What this means for you

If you’re building deep tech, structure your roadmap around “capital-to-milestone” and make sure each milestone unlocks both a technical and a commercial step — a customer contract, a strategic partnership, a regulatory clearance. Mix VC equity with non-dilutive grant funding wherever possible. It changes the dilution profile of the company materially over a long development timeline.

Frequently Asked Questions

Q: What is Technology Readiness Level (TRL) and how do investors use it? A: TRL is a 1–9 scale for measuring technology maturity, developed by NASA and widely used by defense and deep tech investors. TRL 1–3 represents fundamental research and concept validation; TRL 4–6 represents lab demonstration and prototype; TRL 7–9 represents pilot deployment and production readiness. Deep tech investors typically fund at TRL 3–5 and expect their capital to advance the company to TRL 6–7, the point where commercial contracts become achievable.

Q: How do deep tech companies get non-dilutive government funding? A: US deep tech startups can access non-dilutive funding through SBIR (Small Business Innovation Research) grants of $150k–$2M, DARPA and ARPA-E direct contracts, DoE loan guarantees, and IRA-funded climate technology programs. These programs require significant reporting and compliance overhead but provide capital without equity dilution — materially improving founder and investor ownership percentages over a 10-year development timeline.

Q: Why are deep tech exit multiples higher than SaaS? A: Deep tech companies with proven IP moats — novel manufacturing processes, granted patents in defensible categories, exclusive government contracts — typically sell to strategic acquirers (large industrial, pharmaceutical, or defense companies) who pay for technology access they cannot build internally. These strategic acquisitions often occur at 10–20x revenue multiples versus 4–8x for SaaS, because the acquirer is pricing years of R&D avoidance and competitive exclusion, not just revenue streams.

Q: What is the “capital-to-milestone” framework for deep tech fundraising? A: Capital-to-milestone means structuring each funding round to deliver precisely the technical and commercial progress needed to unlock the next funding round — and no more. A $5M round should produce a TRL advancement, a signed pilot contract, or a regulatory clearance that justifies a $15M–$20M next round. Raising $3M for a $30M problem produces a partial result that impresses no one and leaves the company in a bridge funding trap.

Q: Which government programs co-invest alongside venture in deep tech? A: US programs that co-invest alongside venture capital include DARPA (defense), ARPA-E (energy), DIU (defense commercialization), NIST Manufacturing USA, and DOE loan programs. In the EU, Horizon Europe, EIC Accelerator, and national sovereign innovation funds (UK ARIA, French Bpifrance, German HTGF) provide direct grants and equity-free funding. These programs collectively deployed over $50B in deep tech co-investment in 2023–2024.

CTA: Test how your deep tech roadmap maps to investor logic inside CrackTheDeck — milestones, capital efficiency, dilution profile and exit math.